Amplia announces A$25m Placement and Launches A$2.5m SPP
Filed with ASX · · 5 pages · English
Amplia Therapeutics Ltd. on 6ix
In the deck
Story so far
Earlier from Amplia Therapeutics
- Second Complete Response in ACCENT Pancreatic Cancer Trial
- Pathological complete response recorded in patient from ACCENT cancer trial
- Pathological Complete Response in Pancreatic Cancer Trial
- Preliminary Final Report and Annual Report YE 31 March 2025
- ACCENT Trial Achieves Superiority over Chemotherapy Alone
Later from Amplia Therapeutics
- Capital Raising Presentation
- Positive ACCENT Trial Topline Data Released
- Amplia Share Purchase Plan Raises $2.65 Million
- First patient dosed in new pancreatic cancer trial
- Amplia Receives R&D Tax Rebate Totalling $3.77 Million
Follow Amplia Therapeutics into a list and get an email when it puts out news.
Follow Amplia Therapeutics